Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Infliximab · Avsola, Renflexis

Monoclonal antibody · Inhibitor of tumor necrosis factor alpha (TNF) · developed by Centocor

Approved FDA, Aug 1998
1 Registered trials

What is Infliximab?

Infliximab is a chimeric monoclonal antibody that binds with high affinity to soluble and transmembrane forms of tumor necrosis factor alpha (TNFα), blocking its binding to receptors and neutralizing its pro-inflammatory activity. It is used in inflammatory diseases including Crohn's disease, ulcerative colitis, and rheumatoid arthritis.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Avsola, Renflexis, Zymfentra, TA-650, Avakine, cA2, Remicade, Remsima
Drug type
Monoclonal antibody
Targets
tumor necrosis factor alpha (TNF)
Mechanism
Inhibitor of tumor necrosis factor alpha (TNF)
Pathways
pro-inflammatory cytokine induction (IL-1, IL-6), leukocyte migration and adhesion molecule expression, lysis of cells expressing transmembrane TNF
Therapy area
Oncology
Developer
Centocor Inc
In trials of
JNJ
FDA status
Approved as Avsola, Renflexis, Zymfentra (August 24, 1998), BLA103772 · FDA label
UNII
B72HH48FLU

✅ FDA-approved uses

From the indications section of the FDA label (version of Feb 11, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT07657312 Phase 2 Cytokine Release Syndrome Recruiting JNJ

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Cytokine Release SyndromeRecurrent Multiple MyelomaRefractory Multiple Myeloma

Other drugs acting on TNF

Sources

Updated Nov 1, 2026.

Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.